选择性动脉栓塞治疗原发性肝癌破裂出血的临床应用

Clinical Application of Selective Arterial Embolization in the Treatment of Primary Liver Cancer Rupture Hemorrhage

目的 探讨选择性动脉栓塞治疗原发性肝癌破裂出血的临床应用效果。方法 在医院2014年11月~2015年8月诊治的原发性肝癌破裂出血患者中抽取63例作研究对象,采取随机数字法将本组研究对象分为观察组（n=32）和对照组（n=31）,观察组采取选择性动脉栓塞治疗,对照组采取纱布填塞缝扎止血术治疗,对比两组患者并发症发生率和复发率。结果 观察组的并发症发生率为3.13%,其复发率为0;对照组的并发症发生率为12.90%,其复发率为12.90%;两组患者并发症发生率和复发率的组间比较差异有统计学意义（均P〈0.05）。结论 选择性动脉栓塞治疗原发性肝癌破裂出血的临床应用效果确切,患者无严重并发症,且复发率低。

Objective To investigate the clinical application of selective arterial embolization in the treatment of primary hepatic carcinoma rupture. Methods In the hospital from November 2014 to August 2015,63 cases of patients with primary hepatic carcinoma rupture hemorrhage were selected as the research object. They were divided into observation group（n=32）and control group（n=31）. The observation group was treated with selective arterial embolization. The control group was treated with gauze packing suture. The incidence and recurrence rate were compared between the two groups. Results The complication rate was 3.13% in the observation group,the recurrence rate was 0. The control group was 12.90%,the recurrence rate was 12.90%,the incidence of complications and the recurrence rate of the two groups were statistically significant（P〈0.05）. Conclusion Selective arterial embolization in the treatment of primary hepatic carcinoma rupture and bleeding of the clinical application effect is exact,patients without serious complications,and the recurrence rate is lower.